NCT06402032

Brief Summary

Direct pulp capping technique is one of the oldest known treatments for exposed pulp tissue, and there is a continuous requirement for the most efficient materials to be used in this approach. Successful pulp capping is the usual way to preserve the vitality of tooth and avoid root canal treatment or surgical tooth extraction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 30, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

1.2 years

First QC Date

April 30, 2024

Last Update Submit

May 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success Rate (Clinical evaluation)

    Teeth with vital pulp (numerical values with electric pulp tester) and absence of clinical signs/symptoms (Visual Analog Score for pain) as one reported value indicating clinical success rate (%)

    after 12 weeks

Secondary Outcomes (2)

  • Histomorphometric analysis (Histologic evaluation)

    after 12 weeks

  • Histomorphometric analysis (Histologic evaluation)

    after 12 weeks

Study Arms (2)

Hesperidin

EXPERIMENTAL
Other: Hesperidin

Mineral trioxide aggregate (MTA)

ACTIVE COMPARATOR
Other: Mineral Trioxide Aggregate (MTA)

Interventions

Hesperidin is a natural flavonoid with well-known of its anti-inflammatory properties in many disease. Hesperidin in previous studies has been documented to reduce inflammation as well as pain through suppression of cytokine production, NF-κB activity, and oxidative stress. Hesperidin, as a natural product, have been considered as a promising pulp capping material in several invitro and animal studies. However, the regenerative effect of hesperidin as pulp capping material in human teeth has not yet been reported.

Hesperidin

Mineral trioxide aggregate is a cementitious material having various advantages as it is biocompatible, bioactive, osteo-inductive, non-resorbable material with exciting clinical applications, stimulating reparative continuous dentin formation along with maintaining the integrity of the pulp. Moreover, mineral trioxide aggregate provides seal to tooth structure and is of high strength. It is considered the gold standard material for direct pulp capping.

Mineral trioxide aggregate (MTA)

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Good oral hygiene,
  • Sound wisdom teeth with closed apices with normal pulp vitality response
  • No periodontal disease or periapical lesions on periapical radiograph
  • Cooperative patients approving to participate in the study

You may not qualify if:

  • Medically compromised participants
  • Evidence of parafunctional habits
  • Heavy smokers
  • Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis
  • Severe periodontal problems or pathological periapical changes
  • Teeth with open apex or pulp calcification

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Dental Pulp Exposure

Interventions

Hesperidinmineral trioxide aggregate

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

FlavanonesFlavonoidsChromonesBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingGlycosidesCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Faculty of Dentistry

Study Record Dates

First Submitted

April 30, 2024

First Posted

May 7, 2024

Study Start

September 1, 2022

Primary Completion

December 1, 2023

Study Completion

March 30, 2024

Last Updated

May 7, 2024

Record last verified: 2024-05

Locations